The lack of EPO or EPOR correlation by IHC in RCC vs. benign samples substantiates a previous large cohort (n = 195) reported by Papworth et al.[21], but is contradictory to two small studies from Asia (combine n = 129) [56,57]. The gene discussed is EPO; the disease is renal cell carcinoma.